ATE198982T1 - Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen - Google Patents
Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzenInfo
- Publication number
- ATE198982T1 ATE198982T1 AT95934711T AT95934711T ATE198982T1 AT E198982 T1 ATE198982 T1 AT E198982T1 AT 95934711 T AT95934711 T AT 95934711T AT 95934711 T AT95934711 T AT 95934711T AT E198982 T1 ATE198982 T1 AT E198982T1
- Authority
- AT
- Austria
- Prior art keywords
- pct
- active substance
- dosage forms
- pharmaceutically active
- pharmaceutical dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9421836A GB9421836D0 (en) | 1994-10-28 | 1994-10-28 | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
PCT/GB1995/002485 WO1996013251A1 (en) | 1994-10-28 | 1995-10-20 | Process for preparing solid pharmaceutical dosage forms of hydrophobic substances |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE198982T1 true ATE198982T1 (de) | 2001-02-15 |
Family
ID=10763606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95934711T ATE198982T1 (de) | 1994-10-28 | 1995-10-20 | Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen |
Country Status (16)
Country | Link |
---|---|
US (1) | US5827541A (de) |
EP (1) | EP0737064B1 (de) |
JP (1) | JPH09511255A (de) |
KR (1) | KR100352881B1 (de) |
CN (1) | CN1236762C (de) |
AT (1) | ATE198982T1 (de) |
AU (1) | AU3702795A (de) |
DE (1) | DE69520036T2 (de) |
DK (1) | DK0737064T3 (de) |
ES (1) | ES2154737T3 (de) |
GB (1) | GB9421836D0 (de) |
GR (1) | GR3035427T3 (de) |
MX (1) | MX9602515A (de) |
PL (1) | PL187254B1 (de) |
PT (1) | PT737064E (de) |
WO (1) | WO1996013251A1 (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9517062D0 (en) | 1995-08-18 | 1995-10-25 | Scherer Ltd R P | Pharmaceutical compositions |
GB9702799D0 (en) * | 1997-02-12 | 1997-04-02 | Scherer Corp R P | Process for preparing solid pharmaceutical dosage forms |
US6277458B1 (en) * | 1999-03-15 | 2001-08-21 | The Procter & Gamble Company | Release strip with partible break to facilitate |
US5976577A (en) * | 1997-07-11 | 1999-11-02 | Rp Scherer Corporation | Process for preparing fast dispersing solid oral dosage form |
US6852337B2 (en) | 1998-04-09 | 2005-02-08 | Roche Diagnostics Gmbh | Carvedilol-galenics |
US8236352B2 (en) | 1998-10-01 | 2012-08-07 | Alkermes Pharma Ireland Limited | Glipizide compositions |
US20040013613A1 (en) * | 2001-05-18 | 2004-01-22 | Jain Rajeev A | Rapidly disintegrating solid oral dosage form |
JP4809533B2 (ja) | 1998-11-20 | 2011-11-09 | オバン・エナジー・リミテッド | 分散し得るリン脂質で安定化されたミクロ粒子 |
US20010053791A1 (en) * | 2000-03-16 | 2001-12-20 | Babcock Walter C. | Glycogen phosphorylase inhibitor |
US6316029B1 (en) | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
US20020036154A1 (en) * | 2000-08-10 | 2002-03-28 | Ramaswamy Murari | Solid pharmaceutical dosage formulation of hydrophobic drugs |
US6814978B2 (en) | 2000-12-29 | 2004-11-09 | Mcneil-Ppc, Inc. | Process for preparing a soft tablet |
US20030157170A1 (en) * | 2001-03-13 | 2003-08-21 | Richard Liggins | Micellar drug delivery vehicles and precursors thereto and uses thereof |
EP1418945A2 (de) | 2001-03-13 | 2004-05-19 | Angiotech Pharmaceuticals, Inc. | Mizellare arzneimittelabgabe vehikel und ihre anwendungen |
EP1800670A1 (de) * | 2001-04-20 | 2007-06-27 | The University of British Columbia | Mizellares Arzneistoffverabreichungssystem für hydrophobe Arzneistoffe |
US20030153590A1 (en) * | 2001-08-14 | 2003-08-14 | Oy Contral Pharma Ltd | Method of treating alcoholism or alcohol abuse |
PT1443912E (pt) * | 2001-10-12 | 2007-11-28 | Elan Pharma Int Ltd | Composições tendo uma combinação de características de libertação imediata e de libertação controlada |
EP1941878A1 (de) | 2002-01-10 | 2008-07-09 | Biovail Laboratories International Srl | Sedative Formulierungen ohne Benzodiazepin |
MXPA04007428A (es) * | 2002-02-01 | 2004-10-11 | Pfizer Prod Inc | Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido. |
AU2003222027A1 (en) * | 2002-03-20 | 2003-10-08 | Elan Pharma International Limited | Fast dissolving dosage forms having reduced friability |
US20040029843A1 (en) * | 2002-06-20 | 2004-02-12 | Orapharma, Inc. | Rapidly disintegrating formulations for treating or preventing mucositis |
US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
FR2845914B1 (fr) * | 2002-10-18 | 2005-11-04 | Schwarz Pharma Lab | Compose antiemetique a desagregation rapide |
AU2003297260A1 (en) * | 2002-11-12 | 2004-06-03 | Elan Pharma International Ltd. | Fast-disintegrating solid dosage forms being not friable and comprising pullulan |
DE602004016123D1 (de) | 2003-03-07 | 2008-10-09 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
ATE418551T1 (de) | 2003-03-07 | 2009-01-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
CA2517573C (en) * | 2003-03-07 | 2011-12-06 | Schering Corporation | Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia |
US20040224024A1 (en) * | 2003-04-23 | 2004-11-11 | Massachusetts Institute Of Technology | Controlled drug release formulations containing polyion complexes |
US20050036977A1 (en) * | 2003-08-11 | 2005-02-17 | Dilip Gole | Taste-masked resinate and preparation thereof |
EP2322195A2 (de) | 2003-11-10 | 2011-05-18 | Reprise Biopharmaceutics, LLC | Pharmazeutische Zusammensetzungen mit niedrigen Dosen von Desmopressin |
DE20321887U1 (de) | 2003-11-10 | 2012-01-20 | Allergan, Inc. | Arzneimittel umfassend niedrige Dosierungen von Desmopressin |
EP1586313A1 (de) * | 2004-04-07 | 2005-10-19 | The Jordanian Pharmaceutical Manufacturing Co. Ltd. | Metoclopramid enthaltende pharmazeutische Zubereitungen und Herstellungsmethode |
WO2007019344A1 (en) | 2005-08-04 | 2007-02-15 | Sirtris Pharmaceuticals, Inc. | Imidazo [2,1-b] thiayole derivatives as sirtuin modulating compounds |
US8048449B2 (en) * | 2005-12-27 | 2011-11-01 | Jubilant Organosys Ltd. | Mouth dissolving pharmaceutical composition and process for preparing the same |
US20070243248A1 (en) * | 2006-04-14 | 2007-10-18 | Cherukuri S Rao | Rapidly disintegrating solid oral dosage form of liquid dispersions |
CN101431895A (zh) * | 2006-05-01 | 2009-05-13 | 卡普里康制药公司 | 新颖的曲坦制剂和制备它们的方法 |
WO2007143675A2 (en) * | 2006-06-05 | 2007-12-13 | Verus Pharmaceuticals, Inc. | Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies |
WO2007143676A2 (en) * | 2006-06-05 | 2007-12-13 | Verus Pharmaceuticals, Inc. | Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms |
AR061485A1 (es) * | 2006-06-15 | 2008-08-27 | Serenex Inc | Composiciones estabilizadas de tetraciclina |
FR2909877B1 (fr) * | 2006-12-13 | 2009-07-10 | Galenix Dev Soc Par Actions Si | Composition pharmaceutique contenat de la 5-chloro-1-[1-[3- (2-oxo-2,3-dihydro-1h-benzimidazol-1-yl)propyl] piperidin-4-yl]-1,3-dihydro-2h-benzimidazol-2-one et son procede de preparation |
US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
WO2011026080A1 (en) | 2009-08-31 | 2011-03-03 | Wilmington Pharmaceuticals, Llc | Fast disintegrating compositions of meloxicam, processes for preparation, and use to treat arthritis and/or pain |
EP2359812A1 (de) | 2010-01-18 | 2011-08-24 | Cephalon France | Lyophilisierte orale Zusammensetzungen |
TR201002084A1 (tr) | 2010-03-19 | 2011-10-21 | Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ | Oral yolla dağılan donepezil tablet formülasyonları ve hazırlama yöntemi |
EP2377522B1 (de) | 2010-04-15 | 2013-01-16 | Sanovel Ilaç Sanayi Ve Ticaret Anonim Sirketi | Formulierungen von im Mund zerfallenden Mirtazapintabletten und Herstellungsverfahren dafür. |
KR20130138768A (ko) | 2010-09-01 | 2013-12-19 | 아레나 파마슈티칼스, 인크. | 5-ht2c 아고니스트의 신속-용해성 투여 형태 |
EP2609911A1 (de) | 2011-12-29 | 2013-07-03 | Sanovel Ilac Sanayi ve Ticaret A.S. | Neuartiges Verfahren zur Herstellung von oral zerfallenden Flurbiprofen-Formulierungen |
US8431155B1 (en) | 2012-04-30 | 2013-04-30 | Veroscience Llc | Bromocriptine formulations |
FR2997766B1 (fr) * | 2012-11-08 | 2015-06-12 | Alain Iltis | Systeme et procede de detection de rayonnement gamma de type gamma camera |
RU2706727C2 (ru) | 2014-09-17 | 2019-11-20 | Стирлайф Индия Прайвит Лимитед | Шипучие композиции и способы их получения и применения |
US11219594B2 (en) | 2015-12-12 | 2022-01-11 | Steerlife India Private Limited | Effervescent compositions of metformin and processes for preparation thereof |
CN105560199B (zh) * | 2016-03-01 | 2018-07-06 | 山东司邦得制药有限公司 | 一种小儿多潘立酮口崩片及其制备方法 |
CN105663055B (zh) * | 2016-03-01 | 2018-07-06 | 山东司邦得制药有限公司 | 一种小儿多潘立酮干混悬剂及其制备方法 |
MX2019007923A (es) | 2016-12-31 | 2019-09-10 | Bioxcel Therapeutics Inc | Uso de dexmedetomidina sublingual para el tratamiento de la agitacion. |
CZ307916B6 (cs) | 2017-05-08 | 2019-08-21 | mcePharma s. r. o. | Orodispergovatelná tableta s biodostupným kurkuminem a její použití |
US10792246B2 (en) | 2018-06-27 | 2020-10-06 | Bioxcel Therapeutics, Inc. | Film formulations containing dexmedetomidine and methods of producing them |
US20240024288A1 (en) | 2019-07-19 | 2024-01-25 | Bioxcel Therapeutics, Inc. | Non-sedating dexmedetomidine treatment regimens |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE45770B1 (en) * | 1976-10-06 | 1982-11-17 | Wyeth John & Brother Ltd | Pharmaceutical dosage forms |
GB1548022A (en) * | 1976-10-06 | 1979-07-04 | Wyeth John & Brother Ltd | Pharmaceutial dosage forms |
GB2111423B (en) * | 1981-12-02 | 1985-06-26 | Wyeth John & Brother Ltd | Making quick-dissolving pills |
ZA828578B (en) * | 1981-12-10 | 1983-09-28 | Hawker Siddeley Revenue Contr | Credit card systems |
FR2561916B1 (fr) * | 1984-03-30 | 1987-12-11 | Lafon Labor | Forme galenique pour administration orale et son procede de preparation par lyophilisation d'une emission huile dans eau |
US5079018A (en) * | 1989-08-14 | 1992-01-07 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
US5039540A (en) * | 1989-08-14 | 1991-08-13 | Neophore Technologies, Inc. | Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs |
FR2661610B1 (fr) * | 1990-05-02 | 1994-09-30 | Rhone Poulenc Sante | Nouvelle forme lyophilisee de la diosmine et sa preparation. |
ATE212235T1 (de) * | 1991-04-08 | 2002-02-15 | Sumitomo Pharma | Poröse feste zubereitung, die eine physiologische aktive proteinverbindung enthält |
MX9300110A (es) * | 1992-01-13 | 1994-07-29 | Gerhard Gergely | Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. |
TW272942B (de) * | 1993-02-10 | 1996-03-21 | Takeda Pharm Industry Co Ltd |
-
1994
- 1994-10-28 GB GB9421836A patent/GB9421836D0/en active Pending
-
1995
- 1995-10-20 PT PT95934711T patent/PT737064E/pt unknown
- 1995-10-20 AU AU37027/95A patent/AU3702795A/en not_active Abandoned
- 1995-10-20 PL PL95315181A patent/PL187254B1/pl unknown
- 1995-10-20 DK DK95934711T patent/DK0737064T3/da active
- 1995-10-20 US US08/663,103 patent/US5827541A/en not_active Expired - Lifetime
- 1995-10-20 EP EP95934711A patent/EP0737064B1/de not_active Expired - Lifetime
- 1995-10-20 MX MX9602515A patent/MX9602515A/es unknown
- 1995-10-20 AT AT95934711T patent/ATE198982T1/de active
- 1995-10-20 JP JP8514378A patent/JPH09511255A/ja active Pending
- 1995-10-20 ES ES95934711T patent/ES2154737T3/es not_active Expired - Lifetime
- 1995-10-20 WO PCT/GB1995/002485 patent/WO1996013251A1/en active IP Right Grant
- 1995-10-20 DE DE69520036T patent/DE69520036T2/de not_active Expired - Lifetime
- 1995-10-20 KR KR1019960703488A patent/KR100352881B1/ko not_active IP Right Cessation
- 1995-10-20 CN CNB951916262A patent/CN1236762C/zh not_active Expired - Lifetime
-
2001
- 2001-02-16 GR GR20010400258T patent/GR3035427T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP0737064B1 (de) | 2001-01-31 |
JPH09511255A (ja) | 1997-11-11 |
GB9421836D0 (en) | 1994-12-14 |
AU3702795A (en) | 1996-05-23 |
MX9602515A (es) | 1997-05-31 |
PL187254B1 (pl) | 2004-06-30 |
KR100352881B1 (ko) | 2003-01-06 |
DE69520036D1 (de) | 2001-03-08 |
PL315181A1 (en) | 1996-10-14 |
ES2154737T3 (es) | 2001-04-16 |
US5827541A (en) | 1998-10-27 |
CN1236762C (zh) | 2006-01-18 |
CN1140408A (zh) | 1997-01-15 |
DE69520036T2 (de) | 2001-06-21 |
WO1996013251A1 (en) | 1996-05-09 |
EP0737064A1 (de) | 1996-10-16 |
DK0737064T3 (da) | 2001-02-26 |
GR3035427T3 (en) | 2001-05-31 |
PT737064E (pt) | 2001-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69520036D1 (de) | Verfahren zur herstellung von festen pharmazeutischen dosierungsformen hydrophobischen substanzen | |
ATE198150T1 (de) | Verfahren zur herstellung fester pharmazeutischer dosierungsform | |
ATE202279T1 (de) | Apparat und verfahren zur herstellung fester formen mit gesteuerter freisetzung des wirkstoffs | |
DE59607490D1 (de) | Verfahren zur herstellung von wirkstoffzubereitungen in form einer festen lösung des wirkstoffs in einer polymermatrix | |
ATE208612T1 (de) | Biologisch erodierbare vorrichtung zur verabreichung von wirkstoffen | |
ATE204469T1 (de) | Verfahren zur herstellung von morphologisch einheitlichen mikrokapseln sowie nach diesem verfahren hergestellte mikrokapseln | |
HUT63954A (en) | Process for producing active ingredient containing microparticldes from hydrolytically degredable polymers | |
DE60130917D1 (de) | Induziertes phasenübergangs verfahren zur herstellung von hydrophile wirkstoffe enthaltende mikropartikeln | |
DE69921941D1 (de) | Verfahren zur Herstellung von pharmazeutischen Wirkstoffpartikeln | |
ATE316779T1 (de) | Implantate zur gesteuerten freisetzung von pharmazeutischen wirkstoffen und verfahren zur herstellung | |
AU3533395A (en) | Oral sustained-release preparation | |
ATE219664T1 (de) | Verfahren zur herstellung fester pharmazeutischer dosisformen | |
ATE221772T1 (de) | Verfahren und apparat zur herstellung von schnelllöslichen dosierungseinheiten und daraus erhältliches produkt | |
DE69001573D1 (de) | Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung. | |
ATE282406T1 (de) | Arzneimittel und verfahren zur behandlung von intrazellulären infektionen | |
DE59509566D1 (de) | Pharmazeutische zubereitung mit einem hydrophoben wirkstoff und einem brausesystem, sowie verfahren zur herstellung der zubereitung | |
DE59611383D1 (de) | Darreichungsform zur applikation von pharmazeutischen wirkstoffen und hilfsstoffen und verfahren zur herstellung derselben | |
GR3034155T3 (en) | Water-soluble epipodophyllotoxin derivatives, preparation method therefor, and use thereof as a drug and for treating cancer | |
DE59604441D1 (de) | Verfahren zur schonenden keimreduzierung von pharmazeutischen zubereitungen | |
GR3032071T3 (en) | Process for producing active substances from unused or discarded devices for the transdermal administration of active substances and/or from their production waste | |
ATE288901T1 (de) | Verfahren zur herstellung von 5-hydroxymethyl-2- oxazolidinon und neues zwischenprodukt | |
DE69813550T2 (de) | Vorrichtung und verfahren zur herstellung von radioaktiven arzneimitteln zur verabreichung | |
ATE126285T1 (de) | Verfahren und vorrichtung zur nassbehandlung von textilmaterialien sowie zur wiedereinstellung eines behandlungsbades. | |
ATE66468T1 (de) | Leukotrienantagonisten, verfahren zu ihrer herstellung und ihre anwendung zur behandlung von krankheiten. | |
UA9522A (uk) | Спосіб лікування аутоімунного тиреоідиту |